KIF2C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.800000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.732800E-01
Normal-vs-Stage2
3.363800E-01
Normal-vs-Stage3
6.921000E-01
Normal-vs-Stage4
5.071200E-01
Stage1-vs-Stage2
2.684600E-01
Stage1-vs-Stage3
8.799000E-01
Stage1-vs-Stage4
6.280200E-01
Stage2-vs-Stage3
4.217200E-01
Stage2-vs-Stage4
5.701600E-01
Stage3-vs-Stage4
7.639000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.875600E-01
Normal-vs-AfricanAmerican
5.899600E-01
Normal-vs-Asian
1.727750E-01
Caucasian-vs-AfricanAmerican
6.588400E-01
Caucasian-vs-Asian
9.024800E-01
AfricanAmerican-vs-Asian
5.527400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.277200E-01
Normal-vs-Female
4.124600E-01
Male-vs-Female
4.199600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.230200E-01
Normal-vs-Age(41-60Yrs)
4.143400E-01
Normal-vs-Age(61-80Yrs)
3.264000E-01
Normal-vs-Age(81-100Yrs)
3.834200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.836800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.833200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.574000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.609400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.832400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.097200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.704000E-01
Normal-vs-Daily Drinker
2.644000E-01
Normal-vs-Weekly Drinker
5.188600E-01
Normal-vs-Occasional Drinker
2.138800E-01
Normal-vs-Social Drinker
2.435600E-01
Non Drinker-vs-Daily Drinker
7.807000E-01
Non Drinker-vs-Weekly Drinker
5.169200E-01
Non Drinker-vs-Occasional Drinker
4.136200E-01
Non Drinker-vs-Social Drinker
8.384000E-01
Daily Drinker-vs-Weekly Drinker
5.894800E-01
Daily Drinker-vs-Occasional Drinker
5.195600E-01
Daily Drinker-vs-Social Drinker
9.599400E-01
Weekly Drinker-vs-Occasional Drinker
7.971200E-01
Weekly Drinker-vs-Social Drinker
5.785800E-01
Occasional Drinker-vs-Social Drinker
5.235600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.409600E-01
Normal-vs-Grade 2
5.824000E-01
Normal-vs-Grade 3
5.994600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.953000E-04
Grade 1-vs-Grade 3
1.009310E-04
Grade 1-vs-Grade 4
5.409600E-01
Grade 2-vs-Grade 3
2.276000E-01
Grade 2-vs-Grade 4
5.824000E-01
Grade 3-vs-Grade 4
5.994600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.371800E-01
Normal-vs-NonDiabetic
3.773200E-01
Diabetic-vs-NonDiabetic
8.120200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.995600E-02
Normal-vs-NoPancreatitis
4.314800E-01
Pancreatitis-vs-NoPancreatitis
6.533900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.103200E-01
Normal-vs-N1
3.826200E-01
N0-vs-N1
9.224000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.253970E-01
Normal-vs-TP53-NonMutant
4.728200E-01
TP53-Mutant-vs-TP53-NonMutant
2.939699999982E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
